Costs-effectiveness and cost components of pharmaceutical and non-pharmaceutical interventions affecting antibiotic resistance outcomes in hospital patients: a systematic literature review

  13 March 2024

A systematic literature review was conducted to evaluate the costs and cost-effectiveness of hospital interventions to reduce antibiotic resistance (ABR). Out of 20,958 articles, 59 (32 pharmaceutical and 27 non-pharmaceutical) interventions met the inclusion criteria. Non-pharmaceutical interventions, such as hygiene measures, had unit costs as low as $1 per patient, contrasting with generally higher pharmaceutical intervention costs. Linezolid-based treatments for methicillin-resistant Staphylococcus aureus were found to be cost-effective compared to vancomycin, with ICERs up to $21,488 per treatment success. This study highlights the need for more efficient resource allocation in addressing antibiotic resistance.

Further reading: BMJ Global Health
Author(s): Kasim Allel et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed